Aspira Pathlab & Diagnostics Ltd.

BSE: 540788

₹113.35

up-down-arrow5.09 (4.70%)

As on 22-May-2026IST

Market cap

info icon

₹117 Cr

Revenue (TTM)

info icon

₹24 Cr

P/E Ratio

info icon

79.6

P/B Ratio

info icon

9.1

Div. Yield

info icon

0 %

Aspira Pathlab Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 103.00 High: 113.67

52 Week Range

Low: 49.00 High: 113.67

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹1 Cr

  • ROEROE information

    18.1 %

  • ROCEROCE information

    19.3 %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    34.6

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    ₹12.5

  • EPSEPS information

    ₹1.4

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    10,293,000

10 Years Aggregate

CFO

₹-1.15 Cr

EBITDA

₹2.00 Cr

Net Profit

₹-12.60 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Aspira Pathlab
71.3 102.4 83.4 84.0 52.4 30.5 --
BSE Healthcare
8.8 8.8 9.7 11.0 27.5 14.1 12.0
As on 22-May-2026
Company
2025
2024
2023
2022
2021
Aspira Pathlab
9.0 52.6 -9.0 -44.2 180.6
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Aspira Pathlab
113.4 116.7 24.2 1.5 5.5 11 79.6 9.1
756.6 39,185.5 4,643.2 464.1 13.7 8.9 101 8.6
9.8 8.5 4.5 0.4 -- 4.3 20.3 0.6
1,630.1 27,275.5 2,762.9 509.8 22.5 21.5 54 10.9
12.2 12.8 0.6 0.2 -- 0.8 -- 0.5
764.1 30,572.6 3,904.6 239.4 13.3 11.1 126.6 13.6
109.2 222.6 51.6 0.7 1.3 1.1 340.9 3.7
NG
116.9 39.2 16.5 -1.4 6.6 -3.6 -- 1.0
16.3 37.0 0.0 -8.7 -- -64.3 -- 3.2
73.0 31.1 27.2 -2.0 -3.4 -287.5 -- -29.8

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Aspira Pathlab

Hospital activities

  • Incorporated

    1973

  • Chairman

    Haseeb A Drabu

  • Managing Director

    Pankaj Shah

  • Headquarters

    Mumbai, Maharashtra

  • Website

    www.aspiradiagnostics.com

Edit peer-selector-edit

FAQs for Aspira Pathlab

The share price of Aspira Pathlab & Diagnostics Ltd is ₹113.35 (BSE) as of 22-May-2026 IST. Aspira Pathlab & Diagnostics Ltd has given a return of 52.44% in the last 3 years.

The P/E ratio of Aspira Pathlab & Diagnostics Ltd is 79.58 times as on 22-May-2026.
The P/B ratio of Aspira Pathlab & Diagnostics Ltd is 9.07 times as on 22-May-2026, a 183 premium to its peers’ median range of 3.21 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
43.37
7.21
2024
0.00
3.15
2023
0.00
2.25
2022
14.96
5.22
2021
21.24
3.53

The 52-week high and low of Aspira Pathlab & Diagnostics Ltd are Rs 113.67 and Rs 49.00 as of 22-May-2026.

Aspira Pathlab & Diagnostics Ltd has a market capitalisation of ₹ 117 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Aspira Pathlab & Diagnostics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.